Pharmaceuticals · India
Top 10 Pharmaceuticals markets in India
The fastest-growing and largest of the 20 sized Pharmaceuticals markets in India, 2023 to 2033, with active clinical trials.
Top 10 Pharmaceuticals markets in IndiaThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in India, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $671 Mn | $7.9 Bn | 27.9% | 4 |
| 2 | Cell Based Immunotherapy | $302 Mn | $3 Bn | 26% | 246 |
| 3 | Cannabidiol (CBD) | $401 Mn | $2.4 Bn | 19.8% | 2 |
| 4 | Cannabis | $617 Mn | $2.8 Bn | 16.5% | 1 |
| 5 | Atopic Dermatitis Drugs | $204 Mn | $841 Mn | 15.2% | 4 |
| 6 | Oncology/Cancer Drugs | $3.2 Bn | $9.5 Bn | 11.4% | 272 |
| 7 | Anti-Aging | $1.6 Bn | $4.6 Bn | 11.1% | 9 |
| 8 | Diabetes Management | $1.4 Bn | $3.7 Bn | 10.1% | 51 |
| 9 | Alzheimer Drugs | $91 Mn | $232 Mn | 9.8% | 7 |
| 10 | Contraceptives Drugs | $458 Mn | $1.2 Bn | 9.8% | 1 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $3.2 Bn | $9.5 Bn | 11.4% | 272 |
| 2 | Anti-Aging | $1.6 Bn | $4.6 Bn | 11.1% | 9 |
| 3 | Diabetes Management | $1.4 Bn | $3.7 Bn | 10.1% | 51 |
| 4 | Gastrointestinal Drugs | $982 Mn | $2 Bn | 7.6% | 165 |
| 5 | Asthma & COPD Drugs | $900 Mn | $1.8 Bn | 7% | 16 |
| 6 | Biosimilars | $671 Mn | $7.9 Bn | 27.9% | 4 |
| 7 | Cannabis | $617 Mn | $2.8 Bn | 16.5% | 1 |
| 8 | HIV Drugs | $546 Mn | $1.3 Bn | 8.8% | 8 |
| 9 | Contraceptives Drugs | $458 Mn | $1.2 Bn | 9.8% | 1 |
| 10 | Cancer Supportive Care Drugs | $451 Mn | $947 Mn | 7.7% | 33 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 27.9% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (26%).
Oncology/Cancer Drugs is the largest, worth about $3.2 Bn in 2023 and $9.5 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
China
Japan
Australia
Hong Kong
Philippines
Singapore
Thailand
Malaysia